Carregant...

Cancer ‘survivor-care’: I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment

WHAT IS KNOWN AND OBJECTIVE: Far more patients are now surviving cancer than ever before because of major advances in the diagnosis and treatment of primary and metastatic malignancy. Adjuvant chemotherapeutic drug and combination regimens have contributed to the success. However, persistent residua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Raffa, R. B.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3249658/
https://ncbi.nlm.nih.gov/pubmed/21729110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2710.2010.01208.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!